Skip to content
Home » Transcript: Annie Jacobsen Interview on Biological War – Modern Wisdom

Transcript: Annie Jacobsen Interview on Biological War – Modern Wisdom

Read the full transcript of investigative journalist Annie Jacobsen’s interview on Modern Wisdom Podcast, July 23, 2026.

EDITOR’S NOTE: In this episode of Modern Wisdom, host Chris Williamson interviews investigative journalist and bestselling author Annie Jacobsen about the overlooked dangers of biological warfare. They discuss why bioweapons may be even more catastrophic than nuclear ones, the history of secret programs (including the Soviet Union’s), the risks of gain-of-function research, and what the first six days of a deliberate or accidental bioweapon outbreak could look like.

Nuclear War vs. Biological War

CHRIS WILLIAMSON: Last time we talked was about how we could blow ourselves to death, and this time we’re talking about how we could infect ourselves to death. Which one’s scarier, nuclear war or biological war?

ANNIE JACOBSEN: It’s equally scary in completely different ways. I think, you know, with nuclear war, the response to that was so many people calling me up and saying like, “Okay, I read your book, I just want to die instantly.” Biological war is tricky and scary because you don’t have to die instantly, and then you have to wonder, “I wish I did.” That’s the sort of bad news first.

CHRIS WILLIAMSON: Is there any good news with biological war?

ANNIE JACOBSEN: There is, because it can be prevented. I mean, unlike nuclear war, which is just an event that happens without warning — it’s literally called an “event without warning” — biological war is an “event with warning,” and that warning window, it’s literally like 12, 24, 36 hours max, but that is the window of time when something can be done.

CHRIS WILLIAMSON: Why do you think biological warfare receives so little public attention compared with nuclear war?

ANNIE JACOBSEN: Yeah, I mean, terrific question. For starters, biological war is illegal. Biological weapons are illegal, and yet biological weapons exist, including now, today, in the 21st century — genetically modified biological weapons for extreme transmission, hypervirulence, and designed to defeat existing vaccines and countermeasures. But it’s illegal, so no one has them, except for they do.

CHRIS WILLIAMSON: Is there something about it being invisible as well? There’s no smoke in the sky.

ANNIE JACOBSEN: I mean, that’s what makes it incredibly sinister, I think. It’s invisible, it’s silent. And when you really just think of this simple idea that a biological weapon — any pathogen, really — is a living munition. It’s alive, and it replicates.

CHRIS WILLIAMSON: It’s a bullet with a mind of its own.

ANNIE JACOBSEN: And it’s self-reproducing. And so once it gets unleashed, it just goes.

The Most Underappreciated Existential Risk

CHRIS WILLIAMSON: Do you think bioweapons are the most underappreciated existential risk of the modern world?

ANNIE JACOBSEN: Well, I came across this chart in the DOD that really freaked me out when I was working on Nuclear War. It’s the weapons of mass destruction, or WMD, threat spectrum. And of course, nuclear weapons are at the far end — the worst, most destructive — but biological weapons are a very close second. And even more frightening, they are considered the most likely to occur, and therefore the most dangerous. This has to do with laboratories doing defensive research on biological weapon countermeasures. So this is where you get really into a lot of catch-22, very politicized debates, which we’re going to stay away from and just talk about it plainly — because no one should be for biological war.

CHRIS WILLIAMSON: What surprised you most about comparing the two, nuclear war and biowar?

ANNIE JACOBSEN: Well, I was equally shocked in two lanes. With nuclear war, I remember when Craig Fugate, who’s Obama’s former FEMA director, told me that there is no plan for population protection in the event of a strategic nuclear attack, because everyone will be dead. That was stunning to me, because this is coming from the guy in charge of it. Equally stunning is that there is a plan for protection in the event of biological war, but it’s not for the population — it’s not for you and me. It’s for the government. It’s for a tiny group of government officials who will live out the attack, or the incident, by the way — it doesn’t have to be an attack, it can be an accident. But this is super creepy, and people should definitely know about it and be very upset when they do.

The Origins of Genetic Engineering

CHRIS WILLIAMSON: Let’s start to creep people out then. Starting at the beginning, how did we learn to engineer biotechnology? What’s the story there?

ANNIE JACOBSEN: Yeah. I mean, people talk about CRISPR now, the CRISPR-Cas gene editing. That’s pretty much third or fourth generation gene editing. So the origin story of gene editing is 1971, in a laboratory at Stanford University in Stanford, California. A Nobel laureate named Paul Berg — he won the Nobel Prize for the work he did — figured out how to create what is called a chimera pathogen. A chimera is like that ancient Greek idea of a monster made up of two different parts. Berg figured out how to create recombinant DNA. That’s the real fundamental term for gene editing. And that was way back in 1971.

CHRIS WILLIAMSON: Recombinant, as in recombining?

ANNIE JACOBSEN: Absolutely. It’s just like it sounds. So much of this is just like it sounds. And that’s where it all began. And then there’s the short and long version of how we got where we are now.

CHRIS WILLIAMSON: What’s the argument for doing genetic engineering?

ANNIE JACOBSEN: The argument, like all dual-use technology, is: you can use it to heal, or you can use it to harm. This is true of every technology going back to when humans invented or discovered fire. You can cook your meat and not get trichinosis, or you can burn down the next tribe over. Every technology has that same component. With bioengineering, the idea — and certainly now, very specifically, where we are today — is that we will work with dangerous pathogens to genetically modify them, so that if a dangerous pathogen is released, we will know how to create a medical countermeasure for it.